Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
Radiation from CT scans can increase risk of leukemia, thyroid cancer

Radiation from CT scans can increase risk of leukemia, thyroid cancer

Deterministic mechanoporation of cells en masse to cure cancer

Deterministic mechanoporation of cells en masse to cure cancer

Cardiac resynchronization therapy improves heart function in cancer survivors

Cardiac resynchronization therapy improves heart function in cancer survivors

Young male cancer survivors may benefit from testosterone replacement therapy

Young male cancer survivors may benefit from testosterone replacement therapy

Drug regimen for lymphoma and RA more likely to put patients with pemphigus into remission

Drug regimen for lymphoma and RA more likely to put patients with pemphigus into remission

Preclinical data on new drug combination to treat neuroblastoma published

Preclinical data on new drug combination to treat neuroblastoma published

Glutamine-blocking compound slows cancer growth, unleashes anti-tumor immune response

Glutamine-blocking compound slows cancer growth, unleashes anti-tumor immune response

New stem cell transplant lowers complications for patients with acute blood cancers

New stem cell transplant lowers complications for patients with acute blood cancers

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

Eisai transfers rights to Royalty Pharma relating to net sales of EZH2 inhibitor outside of Japan

Eisai transfers rights to Royalty Pharma relating to net sales of EZH2 inhibitor outside of Japan

Study: Unusually frequent hospital visit can help spot people at risk of myeloma

Study: Unusually frequent hospital visit can help spot people at risk of myeloma

NCCN publishes new clinical practice guidelines for hematopoietic cell transplantation

NCCN publishes new clinical practice guidelines for hematopoietic cell transplantation

Molecular mechanisms involved in Pixantrone's interactions with cancer DNA discovered

Molecular mechanisms involved in Pixantrone's interactions with cancer DNA discovered

New cellular immunotherapy for cancers

New cellular immunotherapy for cancers

Phase 2 clinical trial of CAR T-cell therapy starts at Atlantic Health System

Phase 2 clinical trial of CAR T-cell therapy starts at Atlantic Health System

New study indicates a way to improve cancer immunotherapy

New study indicates a way to improve cancer immunotherapy

Antibiotic resistance doubles in just two decades

Antibiotic resistance doubles in just two decades

University Of Minnesota opens clinical trial of first-of-its-kind NK cell cancer immunotherapy

University Of Minnesota opens clinical trial of first-of-its-kind NK cell cancer immunotherapy

Simple blood test can better identify patients at risk of relapse for B-cell lymphoma

Simple blood test can better identify patients at risk of relapse for B-cell lymphoma

Creatine serves as a molecular battery to power killer T cells' fight against cancer

Creatine serves as a molecular battery to power killer T cells' fight against cancer